Show
lines
Total
504
lines found

Current Reports

March 29, 2023
The Board of Directors‘ recommendation on the final dividend for Y2022.
March 28, 2023
Investment in Theramir Ltd.
March 22, 2023
Information on monthly estimated consolidated revenues of February 2023
February 22, 2023
Information on monthly estimated consolidated revenues of January 2023
January 23, 2023
Information on monthly estimated consolidated revenues for December 2022
January 02, 2023
Dates of publication of periodic reports and information on submitting consolidated periodic reports in the financial year 2023.
December 21, 2022
Information on monthly estimated consolidated revenues for November 2022
November 22, 2022
Acquisition of 15.5% shares in RSL Revolutionary Labs Ltd.
November 22, 2022
Information on monthly estimated consolidated revenues of October 2022.
November 09, 2022
Acquisition of 16% shares in PROMED BIOSCIENCE LTD
November 07, 2022
Upward adjustment of the financial forecasts for 2022
November 02, 2022
Resolution of the Board of Directors on payment of the interim dividend for 2022.
October 20, 2022
Information on monthly estimated consolidated revenues of September 2022.
September 21, 2022
Information on monthly estimated consolidated revenues of August 2022
September 02, 2022
Summary of the buy back program
September 02, 2022
Purchase of own shares
August 23, 2022
Purchase of own shares
August 22, 2022
Information on monthly estimated consolidated revenues of July 2022
July 21, 2022
Information on monthly estimated consolidated revenues of June 2022
July 12, 2022
Purchase of own shares
https://investor.asbis.com/info/current-reports.xhtml
Select year first
All months